OpenAI launches GPT-Rosalind to accelerate drug discovery and data analysis
NewsBytes | April 17, 2026 7:39 AM CST
Industry reacts as OpenAI pledges safety
The launch has definitely caught the attention of both tech and pharma circles, especially since two Google DeepMind scientists were recognized in 2024 for AlphaFold, an AI system that predicts protein structures.
Some companies, including IQVIA, even saw their stock dip after the news.
OpenAI says GPT-Rosalind comes with built-in safety checks to prevent misuse, including anything risky like biological weapons, while helping researchers tackle tough problems in drug development more efficiently.
READ NEXT
-
'Test Die' Coffin Therapy Is Trending In Thailand, Japan - Would You Face Death To Reset Your Life ?
-
India Steps Up Hormuz Security, Issues ‘Navy Clearance Only’ Directive After Firing
-
Latest cuff bangles design and stylish look
-
’24’ returns with a bang after 13 years! Anil Kapoor will again create a storm on OTT
-
What is the difference between anxiety and depression? Psychiatrist tells who is more dangerous
